Summary:

The global varicose vein treatment market size reached USD 438.0 Million in 2023.

The market is expected to reach USD 670.8 Million by 2032, exhibiting a growth rate (CAGR) of 4.8% during 2024-2032.

North America leads the market, accounting for the largest varicose vein treatment market share.

Based on the product, the market has been divided into ablation devices (radiofrequency ablation devices, laser ablation devices, and others), sclerotherapy injection, and others. 

Injection sclerotherapy holds the largest share in the varicose vein treatment industry.

Hospitals remain a dominant segment in the market as they have the required infrastructure to offer various types of treatments for varicose veins.

The rising prevalence of varicose veins is a primary driver of the varicose vein treatment market.

Technological advancements in minimally invasive procedures is reshaping the varicose vein treatment market.

Industry Trends and Drivers:

Growing prevalence of varicose veins:

One of the key factors driving the varicose vein treatment market is the growing prevalence of varicose veins worldwide. Sedentary lifestyles, obesity, and an aging population are significant contributors to the increase in varicose veins. These conditions are more common in older adults, especially among women, and with the rise in life expectancy, the number of individuals affected is increasing. As awareness about varicose veins and their potential complications grows, more people are seeking treatment.

Rising awareness and aesthetic concerns:

Increasing awareness about the health risks associated with untreated varicose veins and rising aesthetic concerns are contributing to the growth of the varicose vein treatment market. Untreated varicose veins can lead to complications such as ulcers, blood clots, and chronic venous insufficiency, driving patients to seek medical intervention sooner. Additionally, more individuals are becoming concerned about the cosmetic appearance of varicose veins, prompting them to pursue treatments that not only address the medical issues and improve their physical appearance.

Technological advancements:

Technological advancements in minimally invasive procedures are significantly driving the varicose vein treatment market. Traditional surgical options, such as vein stripping, have been largely replaced by advanced techniques like endovenous laser therapy (EVLT) and radiofrequency ablation (RFA), which offer shorter recovery times, minimal scarring, and higher success rates. These less invasive procedures are becoming the preferred choice for both patients and physicians, fueling market demand.

Request Sample For PDF Report: https://www.imarcgroup.com/varicose-vein-treatment-market/requestsample

Top Varicose Vein Treatment Market Leaders: 

Alma Lasers Ltd. (Sisram Medical Ltd.)

Angiodynamics Inc.

Biolitec AG (BioMed Technology Holdings Ltd.)

Boston Scientific Corporation

Eufoton S.R.L.

Fotona

Medtronic plc

Sciton Inc.

Teleflex Incorporated

The Vein Company

VVT Medical Ltd.

WON TECH Co. Ltd.